an androgen ( stanozolol : 0,15 mg/kg/d ) was systematically associated to the treatment of acute non lymphoblastic leukemias , since the beginning of induction therapy ( vincristin , daunorubicin , prednisone ) and throughout the maintenance period ( 6-mercaptopurine and methotrexate ) .
C0023467
acute non lymphoblastic leukemias
C0011015
daunorubicin